Development of small molecules for the treament of colon cancer

结肠癌仍然是澳大利亚和发达国家癌症相关死亡的主要原因之一。尽管在预防和治疗方面有所改进，但仍然相当需要有效的治疗选择。我们已经鉴定出一种能抑制癌细胞生长的先导化合物。我们将进一步推进这一系列的临床试验，旨在为患者提供一种新的口服分子，对结肠癌具有有效的活性。

Colon cancer remains one of the leading causes of cancer related deaths in Australia and in the developed world. Despite improvements in prevention and therapies, there remains a considerable need for efficacious therapeutic options. We have identified a lead compound inhibiting the growth of cancer cells. We will progress this series further toward clinical trials and aim to provide patients with a new orally available molecule with potent activity against colon cancer.